EP Biocomposites Ltd
₹ 102
-6.42%
01 Jun
- close price
About
Incorporated in 2020, EP Biocomposites Ltd manufactures fibre reinforced polymer products and provides bio toilet solutions[1]
Key Points
- Market Cap ₹ 17.2 Cr.
- Current Price ₹ 102
- High / Low ₹ 150 / 75.5
- Stock P/E 11.8
- Book Value ₹ 71.7
- Dividend Yield 0.00 %
- ROCE 16.3 %
- ROE 12.9 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.0% over last 3 years.
- Company has high debtors of 317 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 3m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 0.57 | 2.95 | 8.06 | 7.12 | 11.43 | 12.01 | 13.64 | |
| 0.53 | 2.49 | 6.66 | 6.15 | 10.02 | 10.23 | 11.40 | |
| Operating Profit | 0.04 | 0.46 | 1.40 | 0.97 | 1.41 | 1.78 | 2.24 |
| OPM % | 7.02% | 15.59% | 17.37% | 13.62% | 12.34% | 14.82% | 16.42% |
| 0.00 | 0.00 | 0.02 | 0.17 | 0.30 | 0.11 | 0.14 | |
| Interest | 0.00 | 0.00 | 0.19 | 0.23 | 0.04 | 0.36 | 0.34 |
| Depreciation | 0.00 | 0.00 | 0.07 | 0.10 | 0.10 | 0.11 | 0.10 |
| Profit before tax | 0.04 | 0.46 | 1.16 | 0.81 | 1.57 | 1.42 | 1.94 |
| Tax % | 25.00% | 23.91% | 31.03% | 28.40% | 26.75% | 27.46% | 24.74% |
| 0.03 | 0.36 | 0.81 | 0.58 | 1.15 | 1.03 | 1.46 | |
| EPS in Rs | 6.00 | 72.00 | 6.88 | 3.45 | 6.84 | 6.13 | 8.68 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 36% |
| 3 Years: | 24% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 32% |
| 3 Years: | 36% |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -19% |
| 1 Year: | -14% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 12% |
| Last Year: | 13% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 1.18 | 1.68 | 1.68 | 1.68 | 1.68 |
| Reserves | -0.02 | 0.34 | 0.82 | 6.73 | 7.88 | 8.91 | 10.37 |
| 0.00 | 0.00 | 4.11 | 1.28 | 1.80 | 2.98 | 2.40 | |
| 0.52 | 0.94 | 3.16 | 2.03 | 3.72 | 3.06 | 4.28 | |
| Total Liabilities | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 18.73 |
| 0.00 | 0.00 | 0.41 | 0.33 | 0.33 | 0.23 | 0.23 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.14 | 0.62 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.55 | 1.33 | 8.86 | 11.39 | 14.61 | 16.26 | 17.88 | |
| Total Assets | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 18.73 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 0.12 | 0.03 | -4.28 | -0.79 | -1.24 | -0.49 | ||
| 0.00 | 0.00 | -0.47 | 0.02 | -0.16 | 0.02 | ||
| 0.00 | 0.00 | 4.76 | 2.81 | 0.49 | 0.82 | ||
| Net Cash Flow | 0.12 | 0.03 | 0.01 | 2.04 | -0.92 | 0.35 | |
| Free Cash Flow | 0.12 | 0.03 | -4.75 | -0.81 | -1.48 | -0.50 | |
| CFO/OP | 300% | 9% | -294% | -44% | -59% | -1% |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 192.11 | 80.42 | 321.53 | 300.41 | 287.40 | 330.05 | 316.83 |
| Inventory Days | 83.65 | 90.25 | 86.83 | 90.58 | 50.13 | 66.66 | 56.54 |
| Days Payable | 349.79 | 128.35 | 161.90 | 104.79 | 143.08 | 97.87 | 113.51 |
| Cash Conversion Cycle | -74.04 | 42.32 | 246.47 | 286.20 | 194.45 | 298.85 | 259.87 |
| Working Capital Days | -57.63 | 25.98 | 156.69 | 255.81 | 217.47 | 270.79 | 237.62 |
| ROCE % | 219.05% | 41.54% | 13.16% | 15.30% | 14.28% | 16.27% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Wastewater Recycled Per Day (Aggregate Capacity) Million Liters Per Day |
|
|||
| Total Permanent Employees Number |
||||
| Trade Receivables Turnover Ratio Times |
||||
| Significant Order - Hubballi Dharwad Smart City INR Crores |
||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Press Release On The Financial Results For The Half Year And Year Ended March 31, 2026
29 May - EP Biocomposites reported FY26 audited results: revenue up 13.6%, EBITDA up 26.2%, PAT up 41.5%.
-
Financial Results For The Year Ended March 31, 2026
26 May - EP Biocomposites approved audited FY26 results; profit rose to Rs 145.83 lakh, revenue Rs 1,363.98 lakh.
-
Board Meeting Outcome for Outcome Of The Board Meeting Along With The Financial Results For The Year Ended March 31, 2026
26 May - Board approved audited FY26 results; profit rose to Rs 145.83 lakh, and IPO proceeds were fully utilized.
-
Board Meeting Intimation for Board Meeting Scheduled To Approve The Financial Results For The Year Ended March 31, 2026
20 May - Board meeting on May 26, 2026 to approve draft audited financial statements for year ended March 31, 2026.
- Closure of Trading Window 31 Mar
Business Overview:[1]
a) EPBL is a flagship entity of EP Kamat
Group.
b) It manufactures and supplies Fibre
Reinforced Polymers (FRP) products
such as Door Shutters, Frames, Laminated
Doors, Biodigester Tanks, Bio Toilets and
Allied Products for Construction and Industrial applications
c) Company has an Aqua Division which offers Sewage & Effluent Treatment Plants for Hotels, Industry, Institutions, Government bodies as well as residential and commercial buildings
d) In FY24, company has added the line
of Fire doors to its portfolio